Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 93 entries
Sorted by: Best Match Show Resources per page
Pancreatic Cancer and Immunotherapy: A Clinical Overview.

Cancers

Timmer FEF, Geboers B, Nieuwenhuizen S, Dijkstra M, Schouten EAC, Puijk RS, de Vries JJJ, van den Tol MP, Bruynzeel AME, Streppel MM, Wilmink JW, van der Vliet HJ, Meijerink MR, Scheffer HJ, de Gruijl TD.
PMID: 34439292
Cancers (Basel). 2021 Aug 17;13(16). doi: 10.3390/cancers13164138.

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with high mortality. The vast majority of patients present with unresectable, advanced stage disease, for whom standard of care chemo(radio)therapy may improve survival by several months. Immunotherapy has led to a...

Cite
Timmer FEF, Geboers B, Nieuwenhuizen S, et al. Pancreatic Cancer and Immunotherapy: A Clinical Overview. Cancers (Basel). 2021;13(16)doi: 10.3390/cancers13164138.
Timmer, F. E. F., Geboers, B., Nieuwenhuizen, S., Dijkstra, M., Schouten, E. A. C., Puijk, R. S., de Vries, J. J. J., van den Tol, M. P., Bruynzeel, A. M. E., Streppel, M. M., Wilmink, J. W., van der Vliet, H. J., Meijerink, M. R., Scheffer, H. J., & de Gruijl, T. D. (2021). Pancreatic Cancer and Immunotherapy: A Clinical Overview. Cancers, 13(16), . https://doi.org/10.3390/cancers13164138
Timmer, Florentine E F, et al. "Pancreatic Cancer and Immunotherapy: A Clinical Overview." Cancers vol. 13,16 (2021). doi: https://doi.org/10.3390/cancers13164138
Timmer FEF, Geboers B, Nieuwenhuizen S, Dijkstra M, Schouten EAC, Puijk RS, de Vries JJJ, van den Tol MP, Bruynzeel AME, Streppel MM, Wilmink JW, van der Vliet HJ, Meijerink MR, Scheffer HJ, de Gruijl TD. Pancreatic Cancer and Immunotherapy: A Clinical Overview. Cancers (Basel). 2021 Aug 17;13(16). doi: 10.3390/cancers13164138. PMID: 34439292; PMCID: PMC8393975.
Copy Download .nbib Format: NLM
Microscale patterning of hydrogel stiffness through light-triggered uncaging of thiols.

Biomaterials science

Mosiewicz KA, Kolb L, van der Vlies AJ, Lutolf MP.
PMID: 32481945
Biomater Sci. 2014 Nov 30;2(11):1640-1651. doi: 10.1039/c4bm00262h. Epub 2014 Sep 04.

Mammalian cell behavior is strongly influenced by physical and chemical cues originating from the extracellular matrix (ECM). In vivo, ECM signals are displayed in a spatiotemporally complex fashion, often composed as gradients and in concentration profiles that change in...

Cite
Mosiewicz KA, Kolb L, van der Vlies AJ, et al. Microscale patterning of hydrogel stiffness through light-triggered uncaging of thiols. Biomater Sci. 2014;2(11):1640-1651doi: 10.1039/c4bm00262h.
Mosiewicz, K. A., Kolb, L., van der Vlies, A. J., & Lutolf, M. P. (2014). Microscale patterning of hydrogel stiffness through light-triggered uncaging of thiols. Biomaterials science, 2(11), 1640-1651. https://doi.org/10.1039/c4bm00262h
Mosiewicz, Katarzyna A, et al. "Microscale patterning of hydrogel stiffness through light-triggered uncaging of thiols." Biomaterials science vol. 2,11 (2014): 1640-1651. doi: https://doi.org/10.1039/c4bm00262h
Mosiewicz KA, Kolb L, van der Vlies AJ, Lutolf MP. Microscale patterning of hydrogel stiffness through light-triggered uncaging of thiols. Biomater Sci. 2014 Nov 30;2(11):1640-1651. doi: 10.1039/c4bm00262h. Epub 2014 Sep 04. PMID: 32481945.
Copy Download .nbib Format: NLM
Elucidating the degradation mechanism of the cathode catalyst of PEFCs by a combination of electrochemical methods and X-ray fluorescence spectroscopy.

Physical chemistry chemical physics : PCCP

Monzó J, van der Vliet DF, Yanson A, Rodriguez P.
PMID: 27464340
Phys Chem Chem Phys. 2016 Aug 10;18(32):22407-15. doi: 10.1039/c6cp03795j.

In this study, we report a methodology which enables the determination of the degradation mechanisms responsible for catalyst deterioration under different accelerated stress protocols (ASPs) by combining measurements of the electrochemical surface area (ECSA) and Pt content (by X-ray...

Cite
Monzó J, van der Vliet DF, Yanson A, et al. Elucidating the degradation mechanism of the cathode catalyst of PEFCs by a combination of electrochemical methods and X-ray fluorescence spectroscopy. Phys Chem Chem Phys. 2016;18(32):22407-15doi: 10.1039/c6cp03795j.
Monzó, J., van der Vliet, D. F., Yanson, A., & Rodriguez, P. (2016). Elucidating the degradation mechanism of the cathode catalyst of PEFCs by a combination of electrochemical methods and X-ray fluorescence spectroscopy. Physical chemistry chemical physics : PCCP, 18(32), 22407-15. https://doi.org/10.1039/c6cp03795j
Monzó, J, et al. "Elucidating the degradation mechanism of the cathode catalyst of PEFCs by a combination of electrochemical methods and X-ray fluorescence spectroscopy." Physical chemistry chemical physics : PCCP vol. 18,32 (2016): 22407-15. doi: https://doi.org/10.1039/c6cp03795j
Monzó J, van der Vliet DF, Yanson A, Rodriguez P. Elucidating the degradation mechanism of the cathode catalyst of PEFCs by a combination of electrochemical methods and X-ray fluorescence spectroscopy. Phys Chem Chem Phys. 2016 Aug 10;18(32):22407-15. doi: 10.1039/c6cp03795j. PMID: 27464340.
Copy Download .nbib Format: NLM
Airborne SARS-CoV-2 in home and hospital environments investigated with a high-powered air sampler.

The Journal of hospital infection

de Man P, Ortiz MA, Bluyssen PM, de Man SJ, Rentmeester MJ, van der Vliet M, Wils EJ, Ong DSY.
PMID: 34752804
J Hosp Infect. 2021 Nov 06; doi: 10.1016/j.jhin.2021.10.018. Epub 2021 Nov 06.

BACKGROUND: The initial aim was to study the effects of face masks worn by recently infected individuals on the airborne spread of SARS-CoV-2, but findings motivated us to proceed with comparing the presence of SARS-CoV-2 in air samples near...

Cite
de Man P, Ortiz MA, Bluyssen PM, et al. Airborne SARS-CoV-2 in home and hospital environments investigated with a high-powered air sampler. J Hosp Infect. 2021;doi: 10.1016/j.jhin.2021.10.018.
de Man, P., Ortiz, M. A., Bluyssen, P. M., de Man, S. J., Rentmeester, M. J., van der Vliet, M., Wils, E. J., & Ong, D. S. Y. (2021). Airborne SARS-CoV-2 in home and hospital environments investigated with a high-powered air sampler. The Journal of hospital infection, . https://doi.org/10.1016/j.jhin.2021.10.018
de Man, P, et al. "Airborne SARS-CoV-2 in home and hospital environments investigated with a high-powered air sampler." The Journal of hospital infection vol. (2021). doi: https://doi.org/10.1016/j.jhin.2021.10.018
de Man P, Ortiz MA, Bluyssen PM, de Man SJ, Rentmeester MJ, van der Vliet M, Wils EJ, Ong DSY. Airborne SARS-CoV-2 in home and hospital environments investigated with a high-powered air sampler. J Hosp Infect. 2021 Nov 06; doi: 10.1016/j.jhin.2021.10.018. Epub 2021 Nov 06. PMID: 34752804; PMCID: PMC8572039.
Copy Download .nbib Format: NLM
Bulldozing β-linked glycolipids for recognition by invariant NKT cells.

Immunotherapy

de Bruin RC, Schneiders FL, Santegoets SJ, Verheul HM, de Gruijl TD, van der Vliet HJ.
PMID: 22263253
Immunotherapy. 2012 Jan;4(1):20.

No abstract available.

Cite
de Bruin RC, Schneiders FL, Santegoets SJ, et al. Bulldozing β-linked glycolipids for recognition by invariant NKT cells. Immunotherapy. 2012;4(1):20
de Bruin, R. C., Schneiders, F. L., Santegoets, S. J., Verheul, H. M., de Gruijl, T. D., & van der Vliet, H. J. (2012). Bulldozing β-linked glycolipids for recognition by invariant NKT cells. Immunotherapy, 4(1), 20.
de Bruin, Renée C G, et al. "Bulldozing β-linked glycolipids for recognition by invariant NKT cells." Immunotherapy vol. 4,1 (2012): 20.
de Bruin RC, Schneiders FL, Santegoets SJ, Verheul HM, de Gruijl TD, van der Vliet HJ. Bulldozing β-linked glycolipids for recognition by invariant NKT cells. Immunotherapy. 2012 Jan;4(1):20. PMID: 22263253.
Copy Download .nbib Format: NLM
Clinical evaluation of the efficacy of methylnaltrexone in resolving constipation induced by different opioid subtypes combined with laboratory analysis of immunomodulatory and antiangiogenic effects of methylnaltrexone.

BMC palliative care

Neefjes EC, van der Vorst MJ, Boddaert MS, Zuurmond WW, van der Vliet HJ, Beeker A, van den Berg HP, van Groeningen CJ, Vrijaldenhoven S, Verheul HM.
PMID: 25165428
BMC Palliat Care. 2014 Aug 20;13:42. doi: 10.1186/1472-684X-13-42. eCollection 2014.

BACKGROUND: Opioid-induced constipation (OIC) is one of the major symptoms in palliative care with a prevalence of 30-50%. Methylnaltrexone for the treatment of OIC is significantly more effective than placebo, but only in about fifty percent of the patients...

Cite
Neefjes EC, van der Vorst MJ, Boddaert MS, et al. Clinical evaluation of the efficacy of methylnaltrexone in resolving constipation induced by different opioid subtypes combined with laboratory analysis of immunomodulatory and antiangiogenic effects of methylnaltrexone. BMC Palliat Care. 2014;13:42doi: 10.1186/1472-684X-13-42.
Neefjes, E. C., van der Vorst, M. J., Boddaert, M. S., Zuurmond, W. W., van der Vliet, H. J., Beeker, A., van den Berg, H. P., van Groeningen, C. J., Vrijaldenhoven, S., & Verheul, H. M. (2014). Clinical evaluation of the efficacy of methylnaltrexone in resolving constipation induced by different opioid subtypes combined with laboratory analysis of immunomodulatory and antiangiogenic effects of methylnaltrexone. BMC palliative care, 1342. https://doi.org/10.1186/1472-684X-13-42
Neefjes, Elisabeth Cw, et al. "Clinical evaluation of the efficacy of methylnaltrexone in resolving constipation induced by different opioid subtypes combined with laboratory analysis of immunomodulatory and antiangiogenic effects of methylnaltrexone." BMC palliative care vol. 13 (2014): 42. doi: https://doi.org/10.1186/1472-684X-13-42
Neefjes EC, van der Vorst MJ, Boddaert MS, Zuurmond WW, van der Vliet HJ, Beeker A, van den Berg HP, van Groeningen CJ, Vrijaldenhoven S, Verheul HM. Clinical evaluation of the efficacy of methylnaltrexone in resolving constipation induced by different opioid subtypes combined with laboratory analysis of immunomodulatory and antiangiogenic effects of methylnaltrexone. BMC Palliat Care. 2014 Aug 20;13:42. doi: 10.1186/1472-684X-13-42. eCollection 2014. PMID: 25165428; PMCID: PMC4145161.
Copy Download .nbib Format: NLM
Treatment of a traumatic carotid-cavernous fistula with a covered stent: some considerations. Case report.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences

Meijer FJ, Van Der Vliet AM.
PMID: 20465898
Interv Neuroradiol. 2009 Jul 29;15(2):191-6. doi: 10.1177/159101990901500209. Epub 2009 Sep 01.

SUMMARY: This article discusses some considerations concerning covered stent placement in a patient with a traumatic direct carotid-cavernous fistula. Our case supports recent reports in the literature that covered stent placement can be an acceptable alternative when detachable balloon...

Cite
Meijer FJ, Van Der Vliet AM. Treatment of a traumatic carotid-cavernous fistula with a covered stent: some considerations. Case report. Interv Neuroradiol. 2009;15(2):191-6doi: 10.1177/159101990901500209.
Meijer, F. J., & Van Der Vliet, A. M. (2009). Treatment of a traumatic carotid-cavernous fistula with a covered stent: some considerations. Case report. Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences, 15(2), 191-6. https://doi.org/10.1177/159101990901500209
Meijer, F J A, and Van Der Vliet, A M. "Treatment of a traumatic carotid-cavernous fistula with a covered stent: some considerations. Case report." Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences vol. 15,2 (2009): 191-6. doi: https://doi.org/10.1177/159101990901500209
Meijer FJ, Van Der Vliet AM. Treatment of a traumatic carotid-cavernous fistula with a covered stent: some considerations. Case report. Interv Neuroradiol. 2009 Jul 29;15(2):191-6. doi: 10.1177/159101990901500209. Epub 2009 Sep 01. PMID: 20465898; PMCID: PMC3299021.
Copy Download .nbib Format: NLM
Corrigendum. Increased DUX4 expression during muscle differentiation correlates with decreased SMCHD1 protein levels at D4Z4.

Epigenetics

Balog J, Thijssen PE, Shadle S, Straasheijm KR, van der Vliet PJ, Krom YD, van den Boogaard ML, de Jong A, Lemmers RJ, Tawil R, Tapscott SJ, van der Maarel SM.
PMID: 27058812
Epigenetics. 2016;11(2):175. doi: 10.1080/15592294.2016.1161273.

No abstract available.

Cite
Balog J, Thijssen PE, Shadle S, et al. Corrigendum. Increased DUX4 expression during muscle differentiation correlates with decreased SMCHD1 protein levels at D4Z4. Epigenetics. 2016;11(2):175doi: 10.1080/15592294.2016.1161273.
Balog, J., Thijssen, P. E., Shadle, S., Straasheijm, K. R., van der Vliet, P. J., Krom, Y. D., van den Boogaard, M. L., de Jong, A., Lemmers, R. J., Tawil, R., Tapscott, S. J., & van der Maarel, S. M. (2016). Corrigendum. Increased DUX4 expression during muscle differentiation correlates with decreased SMCHD1 protein levels at D4Z4. Epigenetics, 11(2), 175. https://doi.org/10.1080/15592294.2016.1161273
Balog, Judit, et al. "Corrigendum. Increased DUX4 expression during muscle differentiation correlates with decreased SMCHD1 protein levels at D4Z4." Epigenetics vol. 11,2 (2016): 175. doi: https://doi.org/10.1080/15592294.2016.1161273
Balog J, Thijssen PE, Shadle S, Straasheijm KR, van der Vliet PJ, Krom YD, van den Boogaard ML, de Jong A, Lemmers RJ, Tawil R, Tapscott SJ, van der Maarel SM. Corrigendum. Increased DUX4 expression during muscle differentiation correlates with decreased SMCHD1 protein levels at D4Z4. Epigenetics. 2016;11(2):175. doi: 10.1080/15592294.2016.1161273. PMID: 27058812; PMCID: PMC4846112.
Copy Download .nbib Format: NLM
Vγ9Vδ2-T cells as antigen presenting cells for iNKT cell based cancer immunotherapy.

Oncoimmunology

Werter IM, Schneiders FL, Scotet E, Verheul HM, de Gruijl TD, van der Vliet HJ.
PMID: 25941612
Oncoimmunology. 2014 Dec 08;3(9):e955343. doi: 10.4161/21624011.2014.955343. eCollection 2014 Oct.

CD1d-restricted invariant natural killer T cells (iNKT) constitute an important immunoregulatory T-cell subset involved in the induction of antitumor immune responses. Here, we provide a view on the recent observation that Vγ9Vδ2-T cells, through trogocytosis of CD1d-containing membrane fragments,...

Cite
Werter IM, Schneiders FL, Scotet E, et al. Vγ9Vδ2-T cells as antigen presenting cells for iNKT cell based cancer immunotherapy. Oncoimmunology. 2014;3(9):e955343doi: 10.4161/21624011.2014.955343.
Werter, I. M., Schneiders, F. L., Scotet, E., Verheul, H. M., de Gruijl, T. D., & van der Vliet, H. J. (2014). Vγ9Vδ2-T cells as antigen presenting cells for iNKT cell based cancer immunotherapy. Oncoimmunology, 3(9), e955343. https://doi.org/10.4161/21624011.2014.955343
Werter, Inge M, et al. "Vγ9Vδ2-T cells as antigen presenting cells for iNKT cell based cancer immunotherapy." Oncoimmunology vol. 3,9 (2014): e955343. doi: https://doi.org/10.4161/21624011.2014.955343
Werter IM, Schneiders FL, Scotet E, Verheul HM, de Gruijl TD, van der Vliet HJ. Vγ9Vδ2-T cells as antigen presenting cells for iNKT cell based cancer immunotherapy. Oncoimmunology. 2014 Dec 08;3(9):e955343. doi: 10.4161/21624011.2014.955343. eCollection 2014 Oct. PMID: 25941612; PMCID: PMC4292710.
Copy Download .nbib Format: NLM
NMR spectra and electrochemical behavior of catechol-bearing block copolymer micelles.

Data in brief

Hasegawa U, Moriyama M, Uyama H, van der Vlies AJ.
PMID: 26217751
Data Brief. 2015 Apr 22;4:1-6. doi: 10.1016/j.dib.2015.04.004. eCollection 2015 Sep.

Here, we provide the NMR spectra and AFM data for antioxidant micelles prepared from amphiphilic PAM-PDA block copolymers composed of a poly(N-acryloyl morpholine) and a redox-active catechol-bearing block with different catechol content. We also provide details of the electrochemical...

Cite
Hasegawa U, Moriyama M, Uyama H, et al. NMR spectra and electrochemical behavior of catechol-bearing block copolymer micelles. Data Brief. 2015;4:1-6doi: 10.1016/j.dib.2015.04.004.
Hasegawa, U., Moriyama, M., Uyama, H., & van der Vlies, A. J. (2015). NMR spectra and electrochemical behavior of catechol-bearing block copolymer micelles. Data in brief, 41-6. https://doi.org/10.1016/j.dib.2015.04.004
Hasegawa, Urara, et al. "NMR spectra and electrochemical behavior of catechol-bearing block copolymer micelles." Data in brief vol. 4 (2015): 1-6. doi: https://doi.org/10.1016/j.dib.2015.04.004
Hasegawa U, Moriyama M, Uyama H, van der Vlies AJ. NMR spectra and electrochemical behavior of catechol-bearing block copolymer micelles. Data Brief. 2015 Apr 22;4:1-6. doi: 10.1016/j.dib.2015.04.004. eCollection 2015 Sep. PMID: 26217751; PMCID: PMC4510377.
Copy Download .nbib Format: NLM
Correction: Prevention of Vγ9Vδ2 T Cell Activation by a Vγ9Vδ2 TCR Nanobody.

Journal of immunology (Baltimore, Md. : 1950)

de Bruin RCG, Stam AGM, Vangone A, van Bergen En Henegouwen PMP, Verheul HMW, Sebestyén Z, Kuball J, Bonvin AMJJ, de Gruijl TD, van der Vliet HJ.
PMID: 28416722
J Immunol. 2017 May 01;198(9):3759. doi: 10.4049/jimmunol.1700317.

No abstract available.

Cite
de Bruin RCG, Stam AGM, Vangone A, et al. Correction: Prevention of Vγ9Vδ2 T Cell Activation by a Vγ9Vδ2 TCR Nanobody. J Immunol. 2017;198(9):3759doi: 10.4049/jimmunol.1700317.
de Bruin, R. C. G., Stam, A. G. M., Vangone, A., van Bergen En Henegouwen, P. M. P., Verheul, H. M. W., Sebestyén, Z., Kuball, J., Bonvin, A. M. J. J., de Gruijl, T. D., & van der Vliet, H. J. (2017). Correction: Prevention of Vγ9Vδ2 T Cell Activation by a Vγ9Vδ2 TCR Nanobody. Journal of immunology (Baltimore, Md. : 1950), 198(9), 3759. https://doi.org/10.4049/jimmunol.1700317
de Bruin, Renée C G, et al. "Correction: Prevention of Vγ9Vδ2 T Cell Activation by a Vγ9Vδ2 TCR Nanobody." Journal of immunology (Baltimore, Md. : 1950) vol. 198,9 (2017): 3759. doi: https://doi.org/10.4049/jimmunol.1700317
de Bruin RCG, Stam AGM, Vangone A, van Bergen En Henegouwen PMP, Verheul HMW, Sebestyén Z, Kuball J, Bonvin AMJJ, de Gruijl TD, van der Vliet HJ. Correction: Prevention of Vγ9Vδ2 T Cell Activation by a Vγ9Vδ2 TCR Nanobody. J Immunol. 2017 May 01;198(9):3759. doi: 10.4049/jimmunol.1700317. PMID: 28416722.
Copy Download .nbib Format: NLM
Oxidation-Dependent Activation of Src Kinase Mediates Epithelial IL-33 Production and Signaling during Acute Airway Allergen Challenge.

Journal of immunology (Baltimore, Md. : 1950)

Dustin CM, Habibovic A, Hristova M, Schiffers C, Morris CR, Lin MJ, Bauer RA, Heppner DE, Daphtary N, Aliyeva M, van der Vliet A.
PMID: 34088769
J Immunol. 2021 Jun 15;206(12):2989-2999. doi: 10.4049/jimmunol.2000995. Epub 2021 Jun 04.

The respiratory epithelium forms the first line of defense against inhaled pathogens and acts as an important source of innate cytokine responses to environmental insults. One critical mediator of these responses is the IL-1 family cytokine IL-33, which is...

Cite
Dustin CM, Habibovic A, Hristova M, et al. Oxidation-Dependent Activation of Src Kinase Mediates Epithelial IL-33 Production and Signaling during Acute Airway Allergen Challenge. J Immunol. 2021;206(12):2989-2999doi: 10.4049/jimmunol.2000995.
Dustin, C. M., Habibovic, A., Hristova, M., Schiffers, C., Morris, C. R., Lin, M. J., Bauer, R. A., Heppner, D. E., Daphtary, N., Aliyeva, M., & van der Vliet, A. (2021). Oxidation-Dependent Activation of Src Kinase Mediates Epithelial IL-33 Production and Signaling during Acute Airway Allergen Challenge. Journal of immunology (Baltimore, Md. : 1950), 206(12), 2989-2999. https://doi.org/10.4049/jimmunol.2000995
Dustin, Christopher M, et al. "Oxidation-Dependent Activation of Src Kinase Mediates Epithelial IL-33 Production and Signaling during Acute Airway Allergen Challenge." Journal of immunology (Baltimore, Md. : 1950) vol. 206,12 (2021): 2989-2999. doi: https://doi.org/10.4049/jimmunol.2000995
Dustin CM, Habibovic A, Hristova M, Schiffers C, Morris CR, Lin MJ, Bauer RA, Heppner DE, Daphtary N, Aliyeva M, van der Vliet A. Oxidation-Dependent Activation of Src Kinase Mediates Epithelial IL-33 Production and Signaling during Acute Airway Allergen Challenge. J Immunol. 2021 Jun 15;206(12):2989-2999. doi: 10.4049/jimmunol.2000995. Epub 2021 Jun 04. PMID: 34088769; PMCID: PMC8642476.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 93 entries